Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA)

被引：20
作者：
Jan H. Hollandt
Malte Mahlerwein
机构：
[1] Klinik Hals Nasen Ohrenheilkunde, Univ. Klin. Schleswig-Holstein, Lübeck, Campus Lubeck
来源：
Sleep and Breathing | 2003年 / 7卷 / 2期
关键词：
Continuous positive airway pressure; Nasal resistance; Side effects; Sleep apnea;
D O I：
10.1007/s11325-003-0087-7
中图分类号：
学科分类号：
摘要：
Although nasal continuous positive airway pressure (nCPAP) treatment is the most efficient therapy for obstructive sleep apnea (OSA), compliance with therapy is poor because of several side effects. Among these adverse effects some are related to the reactions of the nose to nCPAP which are briefly described. In a long-term survey of 109 OSA patients, 80.6% continued nCPAP for at least 3 years until the last follow-up. Follow-up ranged between 0.8 and 109 months with a mean time of 43 (SD ± 24.7) months. Among all patients treated with nCPAP, only 46.6% met our criteria for long-term compliance, defined as a mean use of the CPAP machine for at least 5 hours per night. Within the objective measures such as age, body mass index, neck circumference, nasal airflow, apnea-hypopnea index, minimal oxygen saturation, and level of nCPAP pressure, no predictive factor for daily use of nCPAP could be found. However, pretherapeutic daytime somnolence (measured by visual analogue scale and Epworth Sleepiness Scale) and its improvement obtained from the therapy showed a significant effect on the daily use of the CPAP machine.
引用
收藏
页码：87 / 93
页数：6
相关论文
共 45 条
  • [11] Zwacka G., Scholle S., Kemper G., Rieger B., Nasal CPAP therapy for infants with congenital stridor, Sleep Breath, 2, pp. 85-96, (1997)
  • [12] Loftus B.C., Ahn J., Haddad J., Neonatal nasal deformities secondary to nasal continuous positive airway pressure, Laryngoscope, 104, pp. 1019-1022, (1994)
  • [13] Mortimore I.L., Whittle A.T., Douglas N.J., Comparison of nose and face mask CPAP therapy for sleep apnoea, Thorax, 53, pp. 290-292, (1998)
  • [14] Verse T., Nebenwirkungen der nasalen CPAP-Ventilations-therapie, HNO, 48, pp. 706-715, (2000)
  • [15] Verse T., Lehnhardt E., Pirsig W., Junge-Hulsing B., Kroker B., Otorhinolaryngological side effects of nocturnal nasal ventilation therapy with continuous positive airway pressure (nCPAP), Laryngorhinootologie, 78, pp. 491-496, (1999)
  • [16] Wiest G.H., Ficker J.H., Muller A., Hahn E.G., Nebenwirkungen der nCPAP-Therapie beim obstruktiven Schlafapnoesyndrom. Ursachen und Therapie, Atemw-Lungenkrkh, 24, pp. 95-102, (1998)
  • [17] Lojander J., Brander P.E., Ammala K., Nasopharyngeal symptoms and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome, Acta Otolaryngol., 119, pp. 497-502, (1999)
  • [18] Kalan A., Kenyon G.S., Seemungal T.A.R., Wedzicha A., Adverse effects of positive airway pressure therapy in sleep apnoea syndrome, J. Laryngol. Otol., 113, pp. 888-892, (1999)
  • [19] Nino-Murcia G., McCann C.C., Bliwise D.L., Guilleminault C., Dement W.C., Compliance and side effects in sleep apnea patients treated with nasal continuous positive airway pressure, West J. Med., 150, pp. 165-169, (1999)
  • [20] Togias A.G., Naclerio R.M., Proud D., Et al., Nasal challenge with cold, dry air results in release of inflammatory mediators: Possible mast cell involvement, J. Clin. Invest., 76, pp. 1375-1381, (1985)
12345